ConductScience.org, home

Paper24141007

Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendations.

Giralt S and 17 others. Biol Blood Marrow Transplant, 2014. Cited by 329 papers, by iCite.

Cite this record

ConductScience Library. Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendations. Papers, record 24141007. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24141007

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendations.
PubMed
Journal
Biol Blood Marrow Transplant
PubMed
Year
2014
PubMed
Publication types
Consensus Statement, Guideline, Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
329
iCite
Relative citation ratio, by iCite
10.2
iCite
Revised in PubMed
2026-01-28
PubMed

Authors18

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Giralt SSergio
2Costa LLuciano
3Schriber JJeffrey
4Dipersio JJohn
5Maziarz RRichard
6McCarty JJohn
7Shaughnessy PPaul
8Snyder EEdward
9Bensinger WWilliam
10Copelan EEdward
11Hosing CChitra
12Negrin RRobert
13Petersen FBFinn Bo
14Rondelli DDamiano
15Soiffer RRobert
16Leather HHelen
17Pazzalia AAmy
18Devine SSteven

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hematopoietic Stem Cell MobilizationMajor topic
Hematopoietic Stem Cell TransplantationMajor topic
Heterocyclic CompoundsMajor topic
Hodgkin DiseaseMajor topic
Lymphoma, Non-HodgkinMajor topic
Multiple MyelomaMajor topic
Benzylamines
Cyclams
Filgrastim
Granulocyte Colony-Stimulating Factor
Granulocyte-Macrophage Colony-Stimulating Factor
Humans
Polyethylene Glycols
Recombinant Proteins
Survival Analysis
Transplantation, Autologous

Source PubMed

Download CSV of topics

Cited by171

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 329 citations.

PMIDTitleJournalYearIn PapersSource
42920448Cytarabine-based mobilisation yields higher CD34+ cell counts than cyclophosphamide regardless of prior daratumumab exposure in multiple myeloma.Front Oncol2026https://conductscience.org/library/papers/42920448PubMed
42864656Plerixafor and G-CSF Versus Placebo and G-CSF in Moderately Mobilizing Patients With Multiple Myeloma to Optimize Hematopoietic Stem Cell Collection Results (OPTIMIZE).J Clin Apher2026https://conductscience.org/library/papers/42864656PubMed
42718461A two-phase low-dose ACD-A strategy overcomes hypocalcemia during peripheral blood stem cell collection: a randomized controlled study.Front Oncol2026https://conductscience.org/library/papers/42718461PubMed
42565354Impact of Bone Marrow Involvement on the Success of Hematopoietic Stem Cell Mobilization in Patients With Lymphoma.Cancer Med2026https://conductscience.org/library/papers/42565354PubMed
42440648Non-cryopreserved Autologous Peripheral Blood Stem Cell Transplantation for Lymphoma in a Resource-Limited Setting: Feasibility, Engraftment Kinetics, and Early Outcomes From Kashmir, India.Cureus2026https://conductscience.org/library/papers/42440648PubMed
42360011Safety and Efficacy of Plerixafor in Poor Mobilizers With Lymphoma: A Multicenter, Prospective, Single-Arm Study.Am J Hematol2026https://conductscience.org/library/papers/42360011PubMed
42352409Stem Cell Mobilization and Autologous Transplantation Outcomes After First-Line R-DA-EPOCH in High-Risk DLBCL and HGBCL: A Single-Center Retrospective Study.Cancers (Basel)2026https://conductscience.org/library/papers/42352409PubMed
42338514Febrile neutropenia adversely affects chemomobilization outcomes in patients with multiple myeloma and increases risk for post-transplant infection in those with lymphoma: real-world multicenter data.Blood Sci2026https://conductscience.org/library/papers/42338514PubMed
42123282Pre-Transplant Prognostic Nutritional Index Independently Predicts Progression-Free Survival After Autologous Stem Cell Transplantation in Lymphoma.J Clin Med2026https://conductscience.org/library/papers/42123282PubMed
41952627Cyp7b1-inhibiting azoles enhance hematopoietic stem and progenitor cell mobilization in normal and sickle cell disease mice.Haematologica2026https://conductscience.org/library/papers/41952627PubMed
41739202Superiority of high-dose cytarabine-based mobilisation over cyclophosphamide or plerixafor in primary CNS lymphoma.Ann Hematol2026https://conductscience.org/library/papers/41739202PubMed
41279189Cyp7b1-inhibiting azoles as novel enhancers of hematopoietic stem and progenitor cell mobilization.bioRxiv2025https://conductscience.org/library/papers/41279189PubMed
41128425Streamlining Apheresis: A Dual-Intervention Quality Improvement Initiative to Increase the Efficiency in Stem Cell Collection.J Clin Apher2025https://conductscience.org/library/papers/41128425PubMed
41084581Low Dose Cyclophospahamide is a Feasable Mobilization Regimen in the Covid-19 Era: A Single Center Study from Türkiye.Indian J Hematol Blood Transfus2025https://conductscience.org/library/papers/41084581PubMed
41077583Targeting triple-negative breast cancer using cord-blood CD34⁺ HSPC-derived mesothelin-specific CAR-NKT cells with potent antitumor activity.J Hematol Oncol2025https://conductscience.org/library/papers/41077583PubMed
40932993GroβT rapidly and reliably mobilizes primitive hematopoietic stem and progenitor cells in nonhuman primates.Mol Ther Methods Clin Dev2025https://conductscience.org/library/papers/40932993PubMed
40317777Cost-Effectiveness of Preemptive Plerixafor Versus Rescue Plerixafor for Mobilization and Collection of Hematopoietic Stem Cells in Patients With Multiple Myeloma and Lymphoma.J Clin Apher2025https://conductscience.org/library/papers/40317777PubMed
40281003Impact of single dose of pegfilgrastim on peripheral blood stem cell harvest in patients with multiple myeloma or malignant lymphoma.Sci Rep2025https://conductscience.org/library/papers/40281003PubMed
40238028Clinical benefit loss in myeloma patients declining autologous stem cell transplantation: a real-world study.Discov Oncol2025https://conductscience.org/library/papers/40238028PubMed
40232588Intra-apheresis Cycling to Improve the Clinical Efficacy of Peripheral Blood Stem Cell Donations.Sports Med2025https://conductscience.org/library/papers/40232588PubMed

See all 171 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/24141007

GET https://conductscience.org/api/papers/v1/24141007/cited_by?page=2